HR 4832 · 107th Congress · Health

Prescription Drug Comparative Effectiveness Act of 2002

Introduced 2002-05-23· Sponsored by Rep. Allen, Thomas H. [D-ME-1]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2002-06-03)

Plain Language Summary

[AI summary unavailable — showing source text] Prescription Drug Comparative Effectiveness Act of 2002 - Directs the Director of the Agency for Healthcare Research and Quality to study, analyze, and report to Congress on valid scientific evidence regarding the comparative effectiveness and cost-effectiveness, relative to other drugs and treatments, of prescription drugs that account for high levels of expenditures or use by individuals entitled to benefits under titles XVIII (Medicare) or XIX (Medicaid) of the Social Security Act.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (19)

19 Democrats
Rep. Berry, Marion [D-AR-1]AR
Rep. Langevin, James R. [D-RI-2]RI
Rep. Brown, Sherrod [D-OH-13]OH
Rep. Stark, Fortney Pete [D-CA-13]CA
Rep. Rangel, Charles B. [D-NY-15]NY
Rep. Kaptur, Marcy [D-OH-9]OH
Rep. Baldacci, John Elias [D-ME-2]ME
Rep. DeLauro, Rosa L. [D-CT-3]CT
Rep. Waxman, Henry A. [D-CA-29]CA
Rep. Sandlin, Max [D-TX-1]TX
Rep. Frost, Martin [D-TX-24]TX
Rep. Gephardt, Richard A. [D-MO-3]MO
Rep. Tierney, John F. [D-MA-6]MA
Rep. Barrett, Thomas M. [D-WI-5]WI
Rep. Bonior, David E. [D-MI-10]MI
Del. Norton, Eleanor Holmes [D-DC-At Large]DC
Rep. Thurman, Karen L. [D-FL-5]FL
Rep. Slaughter, Louise McIntosh [D-NY-28]NY
Rep. Miller, George [D-CA-7]CA